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Abstract 
Background: Due to the rising number of type 2 diabetes patients, the antidiabetic drug, metformin is currently 
among those pharmaceuticals with the highest consumption rates worldwide. Via sewage‑treatment plants, met‑
formin enters surface waters where it is frequently detected in low concentrations (µg/L). Since possible adverse 
effects of this substance in aquatic organisms have been insufficiently explored to date, the aim of this study was 
to investigate the impact of metformin on health and development in brown trout (Salmo trutta f. fario) and its 
microbiome.
Results: Brown trout embryos were exposed to 0, 1, 10, 100 and 1000 µg/L metformin over a period from 48 days 
post fertilisation (dpf ) until 8 weeks post‑yolk sac consumption at 7 °C (156 dpf ) and 11 °C (143 dpf ). Chemical analy‑
ses in tissues of exposed fish showed the concentration‑dependent presence of metformin in the larvae. Mortality, 
embryonic development, body length, liver tissue integrity, stress protein levels and swimming behaviour were not 
influenced. However, compared to the controls, the amount of hepatic glycogen was higher in larvae exposed to 
metformin, especially in fish exposed to the lowest metformin concentration of 1 µg/L, which is environmentally 
relevant. At higher metformin concentrations, the glycogen content in the liver showed a high variability, especially 
for larvae exposed to 1000 µg/L metformin. Furthermore, the body weight of fish exposed to 10 and 100 µg/L met‑
formin at 7 °C and to 1 µg/L metformin at 11 °C was decreased compared with the respective controls. The results of 
the microbiome analyses indicated a shift in the bacteria distribution in fish exposed to 1 and 10 µg/L metformin at 
7 °C and to 100 µg/L metformin at 11 °C, leading to an increase of Proteobacteria and a reduction of Firmicutes and 
Actinobacteria.
Conclusions: Overall, weight reduction and the increased glycogen content belong to the described pharmaceuti‑
cal effects of the drug in humans, but this study showed that they also occur in brown trout larvae. The impact of 
a shift in the intestinal microbiome caused by metformin on the immune system and vitality of the host organism 
should be the subject of further research before assessing the environmental relevance of the pharmaceutical.
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Introduction
In recent decades, the rising number of micropollutants 
like industrial chemicals, pharmaceuticals, personal care 
products and pesticides detected in the water cycle has 
become a topic of interest in the public and the scien-
tific community [3, 33, 65]. At the same time, the ana-
lytical instruments and methods were improved, which 
made the detection of these substances in the picogram 
to microgram per litre range possible [1, 3]. In particu-
lar, human pharmaceuticals are constantly discharged 
into water bodies, leading to the continuous exposure 
of aquatic organisms. Since they have a specific mode 
of action and are made to exert an effect in humans, it is 
likely that they have an effect in aquatic non-target organ-
isms [12, 15]. The antidiabetic drug metformin belongs to 
the group of most frequently prescribed pharmaceuticals 
worldwide [24, 32, 34, 70]. In 2015, 590 million defined 
daily doses (DDD) of this drug were prescribed in Ger-
many [64], which resulted in a total prescribed amount of 
1180 t, assuming a DDD of 2 g. The human body excretes 
the pharmaceutical without any metabolisation [5, 60]. 
Although the elimination rates of metformin are > 90% in 
sewage-treatment plants, mostly due to microbial action, 
this compound occurs in surface waters at concentra-
tions up to 3 µg/L [61].
The therapeutic action of metformin in type 2 diabe-
tes patients is the reduction of blood glucose levels by (1) 
the inhibition of hepatic gluconeogenesis and glycogen-
olysis and (2) the activation of glucose uptake into cells 
[2, 30, 47, 75]. Despite the fact that numerous studies 
have addressed the mechanism of action of this drug, it 
is not fully understood to date. Gluconeogenesis—a very 
energy-demanding process—is probably reduced by the 
inhibition of the mitochondrial respiration, which leads 
to a decrease in the ATP/ADP ratio [18, 21, 22, 29]. The 
improved glucose uptake in cells is most likely caused by 
an enhanced glucose transporter capacity and the trans-
location of these transporters into the cell membrane [25, 
30, 43, 75]. Although it is not known whether the same 
mechanisms could be found in fish, it is likely that met-
formin could exert the same effects in their mitochondria 
[26].
In addition to interactions with carbohydrate metabo-
lism, an indirect impact on other metabolic pathways is 
probable and still under investigation. In this context, it 
should be taken into account that, apart from its applica-
tion as an antidiabetic, metformin is also used as a weight 
loss drug [66], for the treatment of the polycystic ovary 
syndrome, a disease which inhibits ovulation and evokes 
high levels of androgens [39, 48], and as an anti-cancer 
drug [42].
It has been demonstrated that metformin exerts simi-
lar therapeutic effects on non-target organisms. For 
example, Crago et  al. [13] detected an increase of vitel-
logenin mRNA in juvenile fathead minnow (Pimephales 
promelas) exposed for 7 days to 1, 10 and 100 µg/L met-
formin. Niemuth and Klaper [50, 51] showed 40  µg/L 
metformin to affect several endocrine-related genes and 
to evoke intersexuality and a reduced size in adult male 
fathead minnows and the reduced fecundity of mat-
ing pairs which had been exposed from the fry stage 
to adulthood for about 1  year. In a further study, Nie-
muth et  al. [49] demonstrated that a concentration of 
40 µg/L metformin increased the vitellogenin mRNA in 
adult fathead minnow exposed for 28  days. Ussery [73] 
showed that metformin reduced the growth of Japanese 
medaka (Oryzias latipes) exposed to 1–100  µg/L met-
formin for 28  days. In contrast, in a report [19] cited 
by Moermond and Smit  [45], a NOEC ≥ 10  mg/L met-
formin was derived for hatching rate, time to hatch, sur-
vival, length and weight in an early-life stage toxicity test 
with zebrafish (Danio rerio). Furthermore, several stud-
ies showed that metformin changed the composition of 
the intestinal microbiome in humans and mice [23, 37, 
67, 77]. This is especially important, since studies found 
a strong correlation between the composition of the gut 
microbiome and the occurrence of diseases [16, 31, 41, 
78]. Moreover, Piro et  al. [54] demonstrated that met-
formin leads to a reduction of enhanced stress protein 
levels caused by exposure to high levels of free fatty acids 
in the pancreatic islets of rats.
In our study, we investigated the impact of metformin 
on the embryonic development and different health indi-
cators of brown trout larvae. Possible embryotoxic effects 
of the drug were investigated by means of a modified fish 
early-life stage test with investigative endpoints includ-
ing mortality, time to hatch, heart rate and growth. Fur-
ther biomarkers concerning the health of brown trout 
larvae were the histopathology of the liver, analyses of 
hepatic glycogen content, stress protein levels, swimming 
behaviour and the intestinal microbiome. With the aim 
of revealing the impact of temperature on potential met-
formin effects, fish were exposed to four concentrations 
of the antidiabetic drug plus a negative control at two 
different temperatures (7  °C and 11  °C). Since the mean 
annual optimal river water temperature for brown trout 
has been determined to be 9  °C [28], we selected two 
temperatures, one lower (7  °C) and one higher (11  °C), 
in order to take the change of seasons into account. The 
exposure experiment was controlled by chemical analysis 
of the metformin concentration in the exposure medium. 
The uptake of metformin into test organisms was also 
characterised.
In the liver of larvae, alterations in tissue integrity were 
examined by histopathological studies. We also deter-
mined the glycogen content in the liver as an important 
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parameter for the energetic status of fish, both by bio-
chemical and histological analyses. Several studies 
showed that chemicals, including pharmaceuticals, can 
lead to the depletion of hepatic glycogen in trout as a 
result of increased energy demand for biotransformation 
[9, 63, 71].
As a general stress marker, the level of heat shock pro-
teins with a weight of 70  kDa (Hsp70) was examined 
in the heads of fish to investigate whether metformin 
can change the Hsp70  level of brown trout. Hsp70 pro-
teins belong to the stress protein family and support the 
folding of the unfolded and the refolding of damaged 
proteins.
As mentioned above, the effects of metformin on the 
intestinal microbiome are a topic of current interest [23, 
77]. Therefore, we studied the microbiome composition 
in the gut of metformin-exposed brown trout.
In addition, the swimming behaviour of fish (total dis-
tance moved and mean velocity) was quantified because 
changes in the energy supply may also manifest in behav-
ioural alterations.
Overall, our study aimed to investigate whether met-
formin negatively influences the vitality of brown trout 
and, if so, whether such health loss is related to changes 
in the gut microbiome or in carbohydrate metabolism.
Materials and methods
Test organisms
For the present study, eggs of brown trout in the eyed-
ova stage (48 dpf) were obtained from a commercial fish 
breeder (trout breeding Lohmühle, D-72275 Alpirsbach-
Ehlenbogen) whose fish breeding is listed as category I 
(disease-free) according to the EC Council Directive [20].
Test substance
Metformin hydrochloride (CAS number: 1115—70—4) 
was purchased from Sigma-Aldrich (Steinheim, Ger-
many; purity 99.9%; Batch number: BCBP0558V). The 
substance was readily soluble in water with a water solu-
bility of 16.56 g/L [69]. The concentrations of metformin 
investigated in the present study refer to metformin free 
base  (C4H11N5) and not the hydrochloride.
Exposure experiments and sampling
Eyed eggs of brown trout (48 dpf, incubation tempera-
ture 8  °C) were exposed directly after purchase to five 
different nominal concentrations of metformin (0, 1, 
10, 100, 1000 µg/L) in triplicate at 7 °C and 11 °C in cli-
mate chambers. The exposure was conducted in a semi-
static system using glass aquaria with 28 test organisms 
per 10 L aquarium. Thus, in total, 840 individuals were 
investigated for their development and health. After 
57  days (for larvae exposed to 11  °C) and 73  days (for 
larvae exposed to 7  °C), depending on the develop-
mental status of the brown trout, half of the fish were 
sampled. These samplings were performed 3  weeks 
post-yolk sac consumption. The other half of the fish 
was sampled after 95  days for brown trout exposed to 
11  °C and 108 days for those at 7  °C. These samplings 
took place 8  weeks after yolk sac consumption of the 
larvae.  In this study, only data of the larvae sampled 8 
weeks post-yolk sac consumption is presented.
Twice a week, 50% of the exposure medium was 
exchanged for freshly prepared medium. For the prepa-
ration of the medium, aerated, filtered tap water (iron 
filter, active charcoal filter, particle filter) was used. The 
medium in the aquaria was aerated with air stones (JBL 
Pro Silent Aeras Micro S2). The light/dark conditions 
were kept constant during the test with a 10  h/14  h—
light/dark cycle. Additionally, the aquaria were shaded 
from direct light with black plastic foil.
During the experiment, the time to hatch and mortal-
ity were recorded every day. The heart rates of fifteen 
larvae from both the control and the treatment with 
the highest metformin concentration (1000  µg/L met-
formin) were counted for 20 s after 21 days of exposure 
for fish at 11 °C and after 37 days of exposure for fish at 
7 °C, when the brown trout were in the finfold resorption 
phase (step 38/39 according to Killeen et al. [35]). There-
fore, the brown trout larvae were transferred to vessels 
containing the respective test medium at the respective 
temperature. For the last 8 weeks of exposure, the larvae 
were fed every day with commercial trout food (INICIO 
plus from Biomar, Denmark) since their yolk sacs had 
already been consumed. The defined amount of food was 
constantly adapted according to the developmental status 
of the brown trout. Excess food and faeces were removed 
during the water exchange. Temperature, pH, oxygen 
content and conductivity were monitored at the begin-
ning and end of the experiment in all treatments as well 
as at days 21 (11 °C) and 37 (7 °C) of the experiment for 
the controls and the highest concentration (details in the 
result chapter and Additional file 1: Paragraph 3). At the 
end of the experiment, the fish were euthanised with an 
overdose of MS  222 (1  g/L tricaine methanesulphonate 
buffered by  NaHCO3) and subsequent severance of the 
spine. The length and weight of fish as well as possible 
abnormalities or injuries were recorded. Due to the small 
size of the test organisms, the fish were separated into 
two groups (details in Additional file  1: Paragraph 10, 
Fig. S3). From the first group, samples for histopathology 
(liver) and chemical tissue analysis (kidney, muscle, and 
head without gills) were obtained. The second group pro-
vided samples for the analyses of hepatic glycogen con-
tent (liver), stress protein levels (head) and the intestinal 
microbiome (gut). Samples for histological analyses were 
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chemically fixed with glutardialdehyde. All other samples 
were immediately frozen in liquid nitrogen and stored at 
− 80 °C.
Chemical analyses
During the experiments, water samples were taken to 
determine the real metformin concentrations in the 
test aquaria. Water samples were taken at the beginning 
(05.01.16) and end of the experiment (11  °C: 08.04.16, 
after 97 days; and 7 °C: 21.04.16, after 108 days), as well 
as at different time points (after 10, 41, 63 and 79 days; 
details in Additional file  1: Paragraph 4, Tables S9 and 
S10) before and after the water exchanges and stored at 
− 20  °C until processing. At the end of the experiment, 
tissue samples of muscle, kidney and head without gills 
were investigated to determine the internal metformin 
concentration in the fish.
Analysis of water concentrations by LC–MS
Quantitative measurements of the water samples were 
performed by LC-MS using a 1260 Infinity HPLC sys-
tem (Agilent Technologies, Waldbronn, Germany) with 
a triple quadrupole mass spectrometer (QqQ-MS: 6490 
Agilent Technologies Santa Clara, CA, USA). A Phe-
nomenex LUNA 5 u HILIC 200 A column (150 × 3 mm; 
5 μm particle size) was used for separation at a flow rate 
of 0.5 mL/min and 40 °C. Eluent A was an aqueous buffer 
with 15  mM ammonium formate and 0.1% formic acid 
(FA), while eluent B was acetonitrile (AcN) with 0.1% 
FA (all chemicals were purchased from Fisher Scientific, 
Schwerte, Germany). A gradient elution was performed: 
using 0–4 min 95% eluent B, decreasing to 50% eluent B 
within 4 min, and then being held for 6 min at 50% elu-
ent B. After switching back to the starting conditions, the 
post time was 8 min. The standard metformin hydrochlo-
ride (> 98%) was purchased from Tokyo Chemical Indus-
try (TCI, Tokyo, Japan). Individual stock solutions with a 
concentration of 1 g/L were prepared in a mixture of AcN 
and water (1:1). All working solutions of the standard 
for direct injection were prepared in AcN and ultrapure 
water (10:1). Stock and working solutions were stored in 
the freezer at − 20 °C, except for the aqueous isotopically 
labelled metformin-d6 solution (from Toronto Research 
Chemicals) which was stored at + 4 °C.
Samples were kept in the autosampler at 10 °C, and the 
injection volume was 10 µL. All samples had a composi-
tion of 90% AcN and 10%  H2O due to dilution (dilution 
factor between 10 and 500). Calibration was performed 
between 0.1 and 10 μg/L in 90% AcN and 10%  H2O with 
metformin-D6 as an internal standard. The concentra-
tion of the internal standard was 1  μg/L in all diluted 
samples and calibration standards. Quantification of 
metformin was achieved after LC separation using a 
6490 triple quadrupole mass spectrometer with the posi-
tive ionisation mode. The electrospray ionisation source 
with an Agilent Jet Stream technology was operated 
under the conditions given in Additional file 1: Table S1. 
The recorded data were processed using the software 
Mass Hunter (Agilent Technologies). For quantifica-
tion and confirmation, two multiple reaction monitoring 
(MRM) transitions were monitored for each analyte in 
the dynamic MRM mode. Details are given in Additional 
file 1: Table S2. The limit of quantification was 1 ng/L for 
metformin. Figures of merit for the analysis method are 
given in Additional file 1: Paragraph 1, Table S3.
Metformin analysis in tissue of brown trout larvae by CE–MS
The metformin concentration in the tissue of brown trout 
fry was determined by capillary electrophoresis–mass 
spectrometry (CE–MS). Fish samples (from the head 
(without the gills) to the tail fin, including the kidney and 
muscle, but not the liver or intestine) originating from all 
exposure concentrations were analysed. For each expo-
sure group, tissue samples of 21 individuals per treatment 
were pooled to reach the required detection limits. After 
the generation of two subsamples per treatment, these 
were measured to determine methodological precision. 
For sample preparation, frozen (− 20  °C) samples were 
first homogenised by grinding using a mortar and pestle 
under liquid nitrogen. A total of 100 mg of the homoge-
nised sample was transferred to an Eppendorf tube; met-
formin-d6 as an internal standard and methanol as the 
extraction solvent were added to make a final concentra-
tion of 291 nmol/L. The tube was vortexed for 30 s, and 
the analytes were extracted under sonication for 15 min. 
Subsequently, the sample was centrifuged at 13,000 g for 
15 min. After filtration using a 45 µm PTFE filter (pore 
size 0.45  μm, Chromafil, Macherey-Nagel, Germany), 
the samples were directly analysed by CE–MS. Quanti-
fication was based on the deuterated internal standard 
metformin-D6 with a detection limit of 0.6 μg/L. Further 
details can be found in Additional file 1: Paragraph 1.
All analyses were performed using an Agilent CE 7100 
interfaced to an Agilent 6550 iFunnel Q-TOF mass spec-
trometer (Agilent Technologies, Waldbronn, Germany 
and Santa Clara, CA, USA) using an electrospray ionisa-
tion source assisted by the sheath-liquid interface. The 
CE separations were carried out by means of an uncoated 
fused-silica capillary (length 80 cm, i.d. 50 µm). The back-
ground electrolyte was a mixture of 100  mM ammonium 
acetate and 3% glacial acetic acid in methanol. Samples 
were injected hydrodynamically by applying a pressure of 
100 mbar for 10 s. The CE capillary was kept at 25 °C during 
CE runs and a voltage of + 30 kV was applied. Details on the 
CE–MS method are given in Additional file 1: Paragraph 1.
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Histopathological investigation
Liver samples for histological analyses (21 per treatment) 
were fixed in 2% glutardialdehyde (25% solution in water; 
Merck KGaA, Darmstadt, Germany) diluted with a caco-
dylate-sodium buffer (0.1 M, pH 7.6; AppliChem GmbH, 
Darmstadt, Germany) for at least 2  weeks. Each liver 
sample was the whole organ of an individual due to the 
small size of the fish. For histopathological analyses, fixed 
liver samples were washed three times for 10 min with the 
same buffer, dehydrated in a graded series of ethanol and 
infiltrated with paraffin wax (Parablast, Leica, Wetzlar, 
Germany) in a tissue processor (TP 1020, Leica). After 
paraffin embedding, samples were cut into 3  µm slices 
using a Leica SM 2000 R microtome. There were eight 
slices per slide from four different planes of the organ. 
One portion of the slices was stained with haematoxy-
lin–eosin (to visualise the nuclei, cytoplasm, connective 
tissue and muscles), and the other with alcian blue-PAS 
(to visualise mucus and glycogen; technical details in 
Additional file 1: Paragraph 2). Analyses were conducted 
using a microscope (Axioskop 2, Zeiss, Oberkochen, Ger-
many). Slides were first examined qualitatively to gain an 
overview and identify pathologies. In a second step, the 
observed pathologies were semi-quantitatively assessed 
and classified into one of five different categories (1: 
control, 2: slight reaction, 3: medium reaction, 4: strong 
reaction, and 5: destruction) according to the criteria pub-
lished by Triebskorn et al. [72]. In a further step, all sam-
ples were analysed a second time after being blinded and 
randomised to avoid an observer bias. In addition, all sec-
tions were categorised according to their glycogen content 
(high, medium and low), again in a blinded and ran-
domised manner. A high glycogen content was described 
by the dark-red staining of glycogen which can be found 
evenly in the whole liver. A bright-red stain and a partial 
spread of glycogen in the liver indicated a medium glyco-
gen content. If almost no glycogen was visible, the sample 
was classified as low glycogen amount.
Stress protein analysis
To determine the level of the 70 kD stress protein family 
(Hsp70) in the fish heads (21 per treatment), the samples 
were homogenised with a mixture of 98% extraction buffer 
and 2% protease inhibitor (3  mL mixture/g sample) as 
described by  Dieterich et  al. [17]. Subsequently, the total 
protein content in the samples was quantified according 
to  Bradford [8]. To assess the level of Hsp70 proteins, a 
standardised amount of 40 µg total protein per sample was 
used for analysis. Using minigel SDS-PAGE, the proteins 
were separated according to their weight. Subsequently, 
the proteins were semi-dry blotted onto a nitrocellulose 
membrane. A primary antibody (monoclonal α-Hsp70 
IgG; Dianova Hamburg, Germany), binding specifically to 
Hsp70 protein, was transferred to the membrane, followed 
by a second antibody (peroxidase-coupled α-IgG; Jackson 
Immunoresearch, West Grove, PA, USA) binding to the 
first. Finally, the membranes were stained with 4-chloro-
1-naphthol, and the optical volume (= band area × aver-
age grey scale value) was quantified relative to an internal 
standard (brown trout whole body homogenate).
Glycogen analysis
For quantification of the glycogen content, the glycogen 
assay from Sigma-Aldrich (MAK016; Steinheim, Ger-
many) was used. Liver samples (number of individuals 
per treatment in Fig.  4) were homogenised with bi-dis-
tilled water (10 µL/mg tissue) on ice. Then, the samples 
were heated to 97 °C for 5 min to inactivate enzymes and 
centrifuged (Eppendorf 5424R) for 5  min at 13,000  g at 
4  °C. Before conducting the assay, the supernatants of 
the samples were diluted 1:15 with bi-distilled water. For 
the assay, 96-well plates were used. Glycogen standards 
(0, 0.4, 0.8, 1.2, 1.6, 1.8, anf 2.0  µg/well) and liver sam-
ples were tested in duplicate. Then, 2 µL of a hydrolysis 
enzyme mix was added per well. In addition to the dupli-
cates per sample, each sample was also pipetted without 
the hydrolysis enzyme mix (sample blank) to determine 
the background signal caused by glucose in the sample. 
The plate was incubated for 30 min at room temperature 
on a shaker. After adding 50  µL of the master reaction 
mix (containing 46 µL development buffer, 2 µL develop-
ment enzyme mix and 2 µL fluorescent peroxidase sub-
strate) per well, the plate was covered in aluminium foil 
and incubated for 30 min on a shaker at room tempera-
ture. Measurements were then conducted in a photom-
eter (BioTek Instruments ELx800G, USA) at 570 nm.
Analyses of swimming behaviour
The swimming behaviour of the test organisms was 
assessed after 90  days of exposure at 11  °C and after 
102 days of exposure at 7  °C. Therefore, five individuals 
per replicate (15 individuals per treatment) were trans-
ferred into smaller square aquaria (17  cm edge-length) 
containing 300  mL of the respective test medium with 
the respective temperature. The fish tracking system 
was placed in the 11  °C climate chamber and the cam-
eras were adjusted for this set up. Therefore, brown trout 
larvae were recorded in the 11 °C climate chamber when 
exposed previously to either 11 °C or 7 °C. From each rep-
licate of the five exposure groups, five larvae were kept in 
one aquarium. After acclimation for 2 min, the swimming 
behaviour of fish was recorded for 18 min using a digital 
camera (Basler acA1300–60 gm camera, 1.3 MP resolu-
tion, Basler AG, Ahrensburg, Germany). The swimming 
behaviour was recorded in four aquaria simultaneously 
and analysed with respect to the total distance moved as 
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well as the mean velocity of each individual using Etho-
Vision 11.5 (Noldus, Wageningen, Netherlands) software. 
Therefore, the centre-point of the fish was tracked. After 
acquisition of the data, a correction of identity swaps 
between the tracked fish was accomplished using the 
Track Editor of EthoVision.
Intestinal microbiome
For investigations of the intestinal microbiome of the 
test organisms, DNA was extracted from gut mucus 
samples and analysed via 16S amplicon-sequencing. 
Prior to the preparation of DNA extraction, the guts 
of the fish were squeezed out and washed with 50  µL 
sterile water to ensure that the gut content were com-
pletely removed. This step was necessary because the 
mucus is closely associated with microvilli in the gut 
[58] and therefore more relevant for the host–symbiont 
relationship and host–symbiont communication than 
the allochthonous microbiome in the gut content. Due 
to the young age of the fish, the guts were too small to 
rinse with peptone water to extract the adherent bacte-
ria of the mucus; therefore, the whole gut was used for 
analysis [57]. The limited lab capacity only allowed us to 
analyse two pooled samples per treatment (each pooled 
sample contained three guts) for the exposure at 11  °C 
and a single pooled sample per treatment for the expo-
sure at 7  °C. DNA was extracted using the QIAamp 
DNA Mini Kit (Qiagen, Hilden, Germany). The DNA 
was eluted in 50  µL of DNAse-free water solution (MP 
Biomedicals Germany GmbH; Eschwege, Germany) and 
quantified via NanoDrop ND-1000 spectrophotometer. 
The V1–V2 region of the 16S rRNA gene was amplified 
using 27F and 338R primers as described previously by 
Camarinha-Silva et  al.  [10]. The forward primer con-
tains a 6-nt barcode and a 2-nt CA-linker. Both primers 
comprised sequences complementary to the Illumina-
specific adaptors to the 5’-ends. Amplification was per-
formed in a total volume of 50 µL with 10× polymerase 
chain reaction (PCR) buffer, each containing dNTPs at a 
concentration of 10  mM, primers at a concentration of 
0.4 µM, 1 µL of template DNA, and 0.25 µL HotStarTaq 
Polymerase (Qiagen, Hilden, Germany). An initial dena-
turation step at 96 °C for 3 min was followed by 15 cycles 
of the following procedure: denaturation at 95  °C for 
10 s, annealing at 55 °C for 10 s, and extension at 72 °C 
for 45  s. One microlitre of this reaction mixture served 
as the template for a second PCR, which was performed 
under the conditions described above, but with 20 cycles, 
using primers designed to integrate the Illumina-multi-
plexing sequences and indices. Non-template controls 
were used. All were free of any amplification products 
after both PCRs. PCR amplicons were verified by aga-
rose gel electrophoresis and quantified by means of the 
Qubit fluorometric quantitation assay (Invitrogen, Carls-
bad, USA). Sequencing was carried out on the Illumina 
MiSeq system using v3 chemistry with 2 × 301 cycles. 
Sequences were demultiplexed using a custom Perl script 
and processed on the Mothur platform [62] accord-
ing to the MiSeq SOP published by Kozich et  al.  [36]. 
Briefly, sequences were filtered by removing sequences 
with ambiguous base calls and homopolymers longer 
than 12 nt and aligned with the Silva database v128 [56]. 
Chimeric sequences were removed using the VSEARCH 
algorithm [59] and sequences were pre-clustered allow-
ing for 3 mismatches. Finally, sequences were classified 
using Silva v128 taxonomy and operational taxonomic 
units (OTUs) were picked at a 97% identity level. Low-
abundance OTUs were removed to reduce the number of 
spurious OTUs.
Statistical analysis
Statistics were analysed using JMP 12 from SAS (Cary, 
NC, USA). If necessary, data were squared to achieve 
normal distribution and homoscedasticity. This trans-
formation was done for the data of the biochemical gly-
cogen analysis and the stress protein analysis at 11  °C. 
The analyses of survival time and time to hatch were 
conducted with COX-regression. The data of the semi-
quantitative histological examination of the tissue and 
the glycogen content were checked for significance with 
the likelihood ratio test. All other parameters were ana-
lysed using a nested ANOVA using the replicate aquaria 
as a nesting factor, followed by Dunnett’s post-hoc test. 
For the statistical analysis of the stress protein level, the 
total distance moved and the mean swimming velocity 
at 11 °C, a Welch-ANOVA was performed since the data 
could not be transformed to reach homoscedasticity. In 
“Results” section, the statistical tests used and the p-val-
ues are shown. Further information (e.g. degrees of free-
dom and F-value) is given in Additional file 1: Paragraph 
11, Table  S15. The α-level was set to 0.05. Because we 
had no replicate climate chambers for 7 °C and 11 °C, we 
refrained from statistically comparing the results obtained 
at the two temperatures to avoid the problem of pseudor-
eplication. Because of the limited number of examined 
replicates, data obtained for the intestinal microbiome 
were not statistically checked for significance. In both 
cases, we restricted comparisons to qualitative aspects.
Credibility of data
Details about the fulfilment of the criteria for reporting 
and evaluation of ecotoxicity data (CRED) according to 
Moermond et al. [44] are given in Additional file 1: Par-
agraph 9, Table S13. CRED helps to improve the repro-
ducibility, consistency and transparency of reliability and 
relevance criteria of ecotoxicity studies [44].
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Results
Water quality parameters
Temperature, pH, oxygen content and conductivity 
were measured at the beginning and end of the experi-
ments (for 7  °C: mean temp. = 7.16 ± 0.30  °C, mean 
pH = 8.05 ± 0.33, mean oxygen = 10.54 ± 0.16  mg/L, 
mean conduct. = 410.43 ± 20.29 µS/cm; for 11 °C: mean 
temp. = 10.74 ± 0.23 °C, mean pH = 8.03 ± 0.13, mean 
oxygen = 9.75 ± 0.15 mg/L, mean conduct. = 431.03 ± 
8.51  µS/cm). Moreover, the water quality parameters 
were measured when the heart rate was recorded (for 
the controls and the highest metformin concentration). 
Further details of the water quality parameters are 
given in Additional file 1: Paragraph 3.
Exposure conditions
The quantification of metformin in the test medium 
revealed a good accordance between the nominal and 
the measured metformin concentrations in our experi-
ment; the recovery was above 80%. Therefore, we refer 
to the nominal concentrations throughout the entire 
study. The real concentrations were shown to be slightly 
lower than the nominal concentrations (Table 1).
In Fig.  1, the tissue concentrations of metformin in 
brown trout larvae are plotted against the measured 
exposure concentrations (for data, also see Table  1). 
Internal metformin concentrations were in the ng/g 
range. At nominal concentrations of the exposure 
medium below 10  µg/L, tissue metformin concentra-
tions were below the limit of detection. The measured 
metformin tissue concentrations of brown trout lar-
vae exposed to 1000  µg/L were higher at 11  °C com-
pared to 7 °C. For the test organisms exposed to 10 and 
100 µg/L, the metformin tissue concentrations did not 
differ between the temperatures in the respective expo-
sure groups.
Investigated developmental and health parameters
In all exposure groups, mortality was between 0.67 and 
4.0% (Table 1) (COX-regression: 7 °C: p = 1; 11 °C: p = 1). 
Mean time to hatch did not differ between the exposure 
groups, at either 7  °C or 11  °C (COX-regression: 7  °C: 
p = 0.4966; 11  °C: p = 0.5853). Concerning the tempera-
ture, the mean time until hatching was about 4 days ear-
lier at 11  °C compared to 7  °C for controls. The heart 
rate did not reveal any differences between the negative 
control and the highest metformin concentration (nested 
ANOVA: 7 °C: p = 0.1590; 11 °C: p = 0.5905) at both tem-
peratures. However, the heart rate of control fish at 11 °C 
was about 21 beats/min higher than that in control fish 
at 7 °C.
Body length and weight
For body weight, the statistical analysis revealed a dif-
ference between treatments at 7  °C and 11  °C (nested 
ANOVA: 7 °C: p < 0.0001; 11 °C: p = 0.0137) with weights 
of brown trout exposed to metformin concentrations 
of 10 and 100  µg/L at 7  °C  being lower compared with 
the negative control (Dunnett’s test: (0  µg/L|10  µg/L): 
p = 0.0072, (0  µg/L|100 µg/L): p = 0.0353). Also, fish 
exposed to 1 µg/L metformin at 11 °C weighed less than 
the negative control (Dunnett’s Test: (0  µg/L|1  µg/L): 
p = 0.0051). Statistical analyses for the body length did 
not show any differences between the treatments at both 
temperatures (nested ANOVA: 7  °C: p = 0.0251 (with 
Dunnett’s Test: p > 0.05); 11  °C: p = 0.9296). In general, 
the brown trout larvae exposed to 11 °C had higher body 
weight and length than the larvae exposed at 7 °C.
Stress protein analyses
Neither the temperature nor metformin had an influence 
on the level of the stress protein Hsp70 in brown trout 
larvae (Table 1) (7 °C: nested ANOVA: p = 0.6287; 11 °C: 
Welch ANOVA: p = 0.1721).
Histological investigations
In general, the liver tissue of the larvae were classified 
as category 1, 2 or 3 and did not show any strong histo-
pathological alterations or severe damage of the tissue. In 
most livers, cells appeared large with a bright cytoplasm 
(Fig. 2A, B) containing high amounts of glycogen (Fig. 2C). 
Nevertheless, a number of individuals also had livers with 
small hepatocytes (Fig. 2D, E) and a low glycogen content 
(Fig. 2F). Small agglomerations of macrophages occurred 
in a few fish livers in all treatments, but further pathologi-
cal changes could not be observed (further details in Addi-
tional file 1: Paragraph 6, Tables S11 and S12). The most 
prominent symptom was a modification of the glycogen 
content. Therefore, this parameter was crucial for the 
assessment values that have been allocated to the respec-
tive samples after semi-quantitative evaluation.
Histological and biochemical glycogen analyses
A qualitative comparison of the control individuals to 
determine whether temperature had an influence on 
the hepatic glycogen level revealed, for both histologi-
cal examination and biochemical analysis, no differ-
ence between 7 and 11 °C. The histological examination 
showed that the liver glycogen amount was categorised 
as ‘high’ for 10 individuals, ‘medium’ for 5 and ‘low’ for 
3 individuals at 7  °C. At 11  °C, there were 9 individu-
als with a glycogen content classified as ‘high’, 5 with a 
‘medium’ glycogen amount and 3 with a ‘low’ one. Focus-
sing solely on the effect of the drug, more individuals 
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Fig. 1 Internal metformin concentration in brown trout larvae after 95 days of exposure at 11 °C and 108 days at 7 °C (ng/g) wet weight vs. 
measured concentration in water (μg/L). At nominal water concentrations of 0 and 1 µg/L metformin, the internal metformin concentrations were 
below the limit of detection
Fig. 2 Representative sections of liver tissue of brown trout fry: A–C: control fish, D–F: fish exposed to 100 µg/L metformin. The controls showed 
large hepatocytes with high amounts of glycogen (stained with alcian blue‑PAS in section C). Livers of fish exposed to metformin showed small 
hepatocytes with low glycogen amount (low staining intensity with alcian blue‑PAS in section F). Sections A, B, D and E were stained with 
haematoxylin–eosin
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of the exposure groups with 1–100  µg/L metformin 
showed a hepatic glycogen content which was catego-
rised as ‘high’ compared to the respective control group 
at 7  °C, especially for 1  µg/L (Fig.  3). At 11  °C, in con-
trast, such a relationship between metformin exposure 
and a ‘high’ glycogen content was not clear, but more 
individuals of the exposure groups with 1–100 µg/L met-
formin show a hepatic glycogen content which was cat-
egorised as ‘medium’ compared to the respective control 
group, again particularly at 1 µg/L; however, these differ-
ences were not significant (Likelihood-Ratio χ2 test: 7 °C: 
p = 0.5211; 11 °C: p = 0.3769).
Also biochemical glycogen measurements (Fig.  4) 
revealed an increase of glycogen content in the livers of 
metformin-exposed larvae when compared to the con-
trol. At 11  °C, this difference was significant only for 
the lowest concentration, but the trend was also visible 
at 7  °C with a p-value slightly higher than 0.05 (nested 
ANOVA: 7  °C: p = 0.0620; 11  °C: p = 0.0085 (with Dun-
nett’s test: (0 µg/L|1 µg/L): p = 0.0024)).
For the intermediate concentrations of metformin 
(10 and 100  µg/L), the biochemical assay revealed an 
increased glycogen content compared to the controls; 
however, the effect was not as strong as for the low-
est metformin concentration. In fish exposed to 11  °C, 
the glycogen content in the 100  µg/L metformin expo-
sure group was distinctly lower compared to the 1 µg/L 
metformin treatment. However, at the highest concen-
tration (1000  µg/L), the inter-individual variation of the 
glycogen amount within the exposure groups was rather 
high. The observed variation in glycogen content was vis-
ible with the histological and biochemical methods.
Behavioural analyses
The temperature of the test medium was shown to have 
an effect on the swimming behaviour of brown trout. 
Control fish that had not experienced metformin and 
were kept at 7 °C swam about 700 cm further in 18 min 
than control fish exposed at 11 °C. Also the velocity was 
about 0.6 cm/s higher at 7  °C compared to 11  °C. Con-
cerning the effect of metformin solely, there was no 
difference of distance moved (7  °C: nested ANOVA: 
p = 0.9216; 11  °C: Welch ANOVA: p = 0.9690) and 
velocity (7  °C: nested ANOVA: p = 0.9215; 11  °C: Welch 
ANOVA: p = 0.9690) between the exposure groups, 
either at 7 °C or at 11 °C.
Microbiome analyses
The microbiome analysis includes 162290 sequences, 
classified into 773 operational taxonomic units (OTUs). 
In total, 98.7% of these sequences belonged to the four 
dominant phyla, Proteobacteria (63.6%), Firmicutes 
(15.2%), Actinobacteria (16.5%) and Bacteroidetes 
(3.4%) comprising a total of 705 OTUs. Keeping the low 
Fig. 3 Semi‑quantitative histological examination of the glycogen amount in the liver of brown trout larvae exposed to metformin at 7 °C and 
11 °C categorised in low, medium and high glycogen contents (Likelihood‑Ratio χ2 test: 7 °C: p = 0.5211; 11 °C: p = 0.3769). The number n of 
examined fish individuals is indicated in the bars
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replicate number of samples in mind, fish exposed to 
1 and 10  µg/L metformin at 7  °C and to 100  µg/L met-
formin at 11  °C seem to hold an intestinal microbiome 
with a different composition than that of the respective 
control fish: The proportion of the Proteobacteria in 
those individuals exposed to these metformin concentra-
tions was found to be increased compared to the control, 
whereas the proportion of the Firmicutes and Actinobac-
teria was reduced (Fig. 5).
Discussion
In the present study, the impact of the antidiabetic drug 
metformin on the development and health of brown 
trout larvae was investigated at 7  °C and 11  °C. The 
parameters focussing on development, such as heart rate 
and time to hatch, did not show any effects of metformin. 
Also mortality, stress protein levels, tissue integrity of 
the liver, body length and swimming behaviour were 
not influenced by metformin. However, an environmen-
tally relevant concentration of 1  µg/L metformin led to 
a significantly enhanced liver glycogen content in brown 
trout larvae and a concentration range of 1–100 µg/L sig-
nificantly decreased the body weight of the larvae. In the 
same concentration range, the investigation of the gut 
microbiome indicated a shift in the bacterial community. 
The observed metformin-induced changes did not follow 
a linear concentration effect relationship.
The chemical analysis of the larval tissue showed a 
concentration-dependent presence of metformin with 
temperature having an effect on the presence of the drug 
in the tissue. In particular for the highest metformin 
concentration, the tissue concentration of the drug was 
higher in fish exposed to 11  °C compared to the lower 
temperature which could be caused by an enhanced 
metabolism and uptake of metformin at higher tempera-
tures. Several studies with mice and humans consuming 
metformin made it clear that the highest concentrations 
of metformin in the body can be found in the gastroin-
testinal tract, kidney and liver [7, 27, 52, 76]. Since the 
samples used for the chemical analysis only contained 
kidney, muscle and head without gills, but not liver or 
gut, the measured metformin concentrations in the tis-
sue of our test organisms were most likely dominated by 
metformin in the kidney—assuming a similar distribu-
tion of metformin in fish as in human or mice. However, 
additional tissue samplings would have been necessary 
to determine whether the maximal tissue uptake capac-
ity for metformin has already been reached at the end of 
Fig. 4 Hepatic glycogen content (measured with the biochemical glycogen assay) of brown trout fry exposed to metformin at 7 °C and 11 °C; 
the number n of examined fish individuals is indicated (reduced number of samples due to pre‑tests and exclusion of values out of calibration 
curve). The line within the boxes represents the median, the boxes are bordered by the 25% to 75% quartiles, the whiskers show the minimum and 
maximum values, the black dots are outliers. The asterisk indicates a significant difference compared with the respective control at the p = 0.05 level 
(nested ANOVA: 7 °C: p = 0.0620; 11 °C: p = 0.0085 (with Dunnett’s Test: (0 µg/L|1 µg/L): p = 0.0024))
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the experiment. Also, one has to keep in mind that we 
could not show possible variations between the individ-
ual test organisms since the tissue samples were pooled 
per treatment.
In our study, metformin did not have any effect on 
mortality and the development of brown trout, since 
even sensitive endpoints such as the heart rate and mean 
time to hatch did not differ between the treatments. 
Consequently, metformin is not embryotoxic for brown 
trout. This assumption is supported by a report  [19] 
cited by Moermond and Smit  [45]. In this report, no 
effects of metformin on hatching rate, time to hatch and 
mortality in an early-life stage test with zebrafish could 
be displayed leading to a no observed effect concentra-
tion (NOEC) of ≥ 10  mg/L for metformin. Ussery [73] 
showed that metformin did not influence mortality, hatch 
success or time to hatch of Japanese medaka exposed to 
1–100 µg/L metformin for 28 days. Likewise, an effect of 
the drug on the body length could not be observed in our 
experiment whereas the weight of brown trout larvae was 
found to be reduced when exposed to 10 and 100  µg/L 
metformin at 7 °C and 1 µg/L at 11 °C. This result reflects 
the use of the antidiabetic as a weight loss drug in human 
at doses of 1.5 to 2.5 g/day [40, 66]. As a potential mecha-
nism responsible for metformin-induced weight loss in 
humans, the downregulation of appetite by attenuating 
the activity of the adenosine monophosphate-activated 
kinase (AMPK) in the hypothalamus has been proposed 
by Malin and Kashyap [40]. In the gastrointestinal tract, 
metformin increases the secretion of glucagon-like pep-
tide 1 (GLP-1), a hormone which functions as satiation 
signal by decreasing the AMPK activity [40]. Moreover, 
two studies with fish also detected a reduction in weight 
at concentrations similar to those in our experiment. 
Niemuth and Klaper [50] showed that fathead-minnows 
weighed less when exposed to 40 µg/L metformin. Ussery 
[73] demonstrated that metformin decreased the weight 
and length of 28 days old Japanese medaka at concentra-
tions of 1–100 µg/L. In contrast, in the assessment report 
mentioned above [19] the growth of zebrafish was not 
influenced by metformin.
The histopathological investigations revealed that the 
livers of the test organisms did not show pathological 
changes except for marginal macrophage agglomerations 
which occurred in a few animals only, but not consist-
ently in a particular treatment. Thus, an effect of met-
formin on the tissue integrity of brown trout liver can be 
excluded.
It was expected that glycogen storage is lower at 11 °C 
than at 7  °C, as energy demands for maintenance and 
activity are increased at higher temperatures [74]. How-
ever, a qualitative comparison of the control individuals 
at the high and low temperatures did not reveal a differ-
ence in the hepatic glycogen content. Likewise, Barton 
Fig. 5 Composition of the intestinal microbiome of brown trout fry exposed to metformin at 7 °C and 11 °C. The analysis focuses on the four 
dominating phyla in the gut: Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes
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and Schreck [6] showed that the glycogen content of juve-
nile Chinook salmon (Oncorhynchus tshawytscha) accli-
mated to 7.5 °C, 12.5 °C and 21.0 °C was reduced more at 
higher temperatures after being exposed to a stressor, but 
was restored to the same level in all temperature groups 
after a certain time. With respect to the influence of met-
formin on glycogen storage in the liver, the biochemical 
analysis showed that the lowest metformin concentration 
(1 µg/L) resulted in a high hepatic glycogen level and the 
histological examination indicated a similar trend. This 
finding can be explained by a limitation of metformin-
triggered glycogenolysis which is one aspect of the ther-
apeutic effect of this drug in humans [14, 25, 75]. With 
both methods, a high variability of the glycogen content 
in the livers of fish exposed to 1000  µg/L metformin 
became obvious. The low hepatic glycogen content in this 
exposure group could be caused by energy demanding 
processes induced by metformin resulting in a reduction 
of the liver glycogen or the reduced uptake of metformin 
in the liver so the drug could not fully exert its pharma-
ceutical effect. To date, we do not have a more detailed 
explanation for this finding.
The stress protein levels did not differ between the 
metformin-treated fish or between the controls exposed 
at the two temperatures. It is known that high base loads 
of stress proteins occur in developing organisms [38, 
53] due to a high demand for the chaperones needed for 
correct protein folding. The high base level of Hsp70 in 
larvae compared to adult fish—as previously shown by 
Murtha and Keller [46] for Danio rerio—could conceal 
the effects of metformin, as described by Piro et al. [54], 
and temperature. To clarify whether or not metformin 
leads to a reduction in the stress protein level in brown 
trout, the Hsp70 level of older fish should be investi-
gated. In a recent experiment conducted with 8-month-
old brown trout, we were able to show that metformin 
did not influence the Hsp70 level, even in those fish 
(fish head was analysed, unpublished data, in Additional 
file 1: Paragraph 7, Fig. S1). Therefore, metformin prob-
ably does not have a reducing effect on the Hsp70 level in 
brown trout, but this cannot be excluded since we inves-
tigated the head in contrast to the pancreas, as in the 
study of Piro et al. [54].
The swimming behaviour of fish was not influenced by 
metformin. Although analyses regarding the energy sta-
tus of the brown trout (hepatic glycogen content) showed 
a difference between the treatments, this effect was not 
reflected by behavioural parameters (distance moved and 
velocity). The study of Godoy et al. [26] also showed that 
the swimming behaviour of zebrafish was not influenced 
by metformin in comparable concentrations of 50 and 
500  µg/L. Concerning the behavioural parameters, one 
can expect that animals exposed at higher temperatures 
move faster than those exposed at lower temperatures. 
The results for behaviour are not consistent with this 
expectation as we observed a higher activity of the lar-
vae exposed at 7  °C. Since the EthoVision-system was 
installed in the climate chamber which was set to 11 °C, 
the higher ambient temperature during the record and 
the acclimatisation time could pose an additional stress 
factor and result in a higher swimming activity of these 
test organisms which were originally exposed at 7 °C.
Microbiological analyses indicated an effect of met-
formin on the intestinal microbiome of brown trout lar-
vae, but this result must be verified by the analyses of the 
other replicates. Low to medium (1 and 10 µg/L at 7  °C 
and 100 µg/L at 11 °C) metformin concentrations led to 
a shift in the composition of the bacterial community of 
brown trout larvae which was also shown for mice and 
human [23, 37, 67, 77]. These effects of metformin on 
the microbiome are most likely caused by an accumu-
lation of the drug in the intestine as shown by several 
studies [4, 27, 76]. In a parallel experiment conducted 
with 12-month-old brown trout, we were able to show 
that the amount of metformin per g tissue in the gut is 
about 3 to 60 times higher than in the kidney, liver or fil-
let (unpublished data, in Additional file  1: Paragraph 8, 
Fig. S2); however, it cannot be excluded that the meas-
ured metformin concentrations in the gut samples were 
influenced by metformin in the gut content, and not only 
determined by the presence of the drug in the tissue of 
the intestine. The different effect concentrations of the 
two temperatures could be explained with respect to the 
temperature preferences of the bacteria. Concerning the 
negative controls at the two temperatures, the proportion 
of Firmicutes was increased at 11  °C compared to 7  °C, 
whereas the proportion of Proteobacteria and Actino-
bacteria was decreased at 11 °C compared to 7 °C. Gen-
erally, a functional interpretation of the changes in the 
microbial community is not yet possible. Future analyses 
will focus on the presence of facultative-pathogenic bac-
teria with relevance for brown trout (e.g. Enterococci, 
Aeromonads) and the presence of species-specific viru-
lence genes to determine whether and how the observed 
changes in the gut microbiome can affect the immune 
system and vitality of brown trout. Forslund et  al. [23] 
have already described the increased expression of viru-
lence factors and gas metabolism genes owing to met-
formin-associated shifts in the human gut microbiome. 
These shifts in the intestinal microbiome may have an 
indirect impact on the immune system [55].
Generally, the observed effects of metformin in brown 
trout concerning body weight, liver glycogen and the 
intestinal microbiome did not follow a linear concentra-
tion-effect relationship. However, a profound mechanis-
tic explanation for this finding cannot be provided since 
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the pharmaceutical action of the drug is still not fully elu-
cidated. Scheen [60] and Graham et al. [27] indicated that 
metformin shows nonlinear pharmacokinetics caused 
by a reduced bioavailability at higher doses. Moreover, 
Chung et  al. [11] revealed that effects on glycaemia did 
not linearly increase with higher doses of metformin in 
humans. The results of these studies led to the assump-
tion that a similar phenomenon could have been possible 
in our study. Thus, metformin did not show an effect at 
the highest concentration. However, it would be favour-
able to complement our results of liver glycogen increase, 
the intestinal microbiome shift and body weight reduc-
tion and focus on the uptake of metformin at different 
concentrations in the identified target organs of the liver, 
intestine and brain to validate the assumptions for the 
nonlinearity of the obtained results.
Concerning the environmental relevance of the drug, it 
has to be stressed that other life stages of brown trout, 
e.g. adults and other species groups, e.g. invertebrates 
could react more sensitively to metformin, especially 
when exposed chronically. In addition to the effects on 
the metabolism of fish, several studies demonstrated 
endocrine effects of metformin such as vitellogenin 
mRNA upregulation or intersexes [13, 49–51] which can 
pose a risk for aquatic organisms and have to be included 
in the assessment of the environmental relevance of the 
drug. Apart from that, guanylurea—the main transfor-
mation product of metformin generated microbially in 
sewage-treatment plants—occurs at even higher concen-
trations than its parent compound in surface waters [61, 
68]; the knowledge concerning its ecotoxicity is scarce, 
but would be required to judge the full ecotoxicological 
impact of metformin.
Conclusions
Our study has made it clear that metformin did not 
induce lethal or embryotoxic effects in brown trout, 
and it became evident that it had no influence on the 
tissue integrity of the liver, on the stress protein level 
and on swimming behaviour or body length. However, 
metformin exerted effects related to the carbohydrate 
metabolism (changes of the liver glycogen), reduced 
body weight and influenced the gut microbiome already 
in low, environmentally relevant concentrations. These 
effects resemble the pharmaceutical effects of metformin 
in humans as antidiabetic and weight loss drug. To date, 
it is not known how the changes in the intestinal micro-
biome which occurred in the same concentration range 
can influence the vitality of the host organism, so further 
research is requested in this field.
The nonlinearity of the concentration–effect rela-
tion of the findings with the presence of effects only 
at low  to  medium metformin concentrations is also 
indicated in other studies, and this might be ascribed 
to the reduced bioavailability of metformin at higher 
doses. However, mechanistic explanations for this 
phenomenon are still lacking, and need to be studied 
further to fully understand metformin’s potential envi-
ronmental impact.
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